ARCHIVES

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

New Publications

January 20, 1989

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

Final Issue Of the Year

December 14, 1990

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000